10-Q: Virgin Galactic Q3 2025: Losses Narrow, Delta Class Progresses

Sentiment:

Quarterly Report


Virgin Galactic reported a narrower net loss in Q3 2025, driven by reduced operating expenses, while advancing its Delta Class spaceship development towards a Q4 2026 commercial flight target.

Delay expectedThe company's commercial spaceflight operations are currently paused as it focuses on developing its next-generation Delta Class spaceships.The flight test program for Delta Class spaceships is expected to commence in Q3 2026, and the first commercial spaceflight (research flight) is expected in Q4 2026, indicating a continued period without revenue-generating flights from its primary service.
Capital raiseThe company has an active 2024 At-The-Market (ATM) Offering Program, under which it sold 30.0 million shares for $109.2 million in gross proceeds during the nine months ended September 30, 2025.As of September 30, 2025, a total of 34.1 million shares have been sold under the 2024 ATM Program, generating $138.3 million in gross proceeds since its inception in November 2024.Management explicitly states that beyond the next twelve months, if current capital sources are insufficient, the company "may need to seek additional debt or equity financing."
Better than expectedNet loss for Q3 2025 was $64.4 million, an improvement from $74.5 million in Q3 2024.Net loss for the nine months ended September 30, 2025, was $216.2 million, an improvement from $270.3 million in the same period of 2024.Operating expenses decreased across all categories for both the three and nine-month periods, indicating improved cost management during a period of development.Net cash used in operating activities decreased to $187.7 million for the nine months ended September 30, 2025, from $271.7 million in the prior year.

Summary

  • Net loss for the three months ended September 30, 2025, was $64.4 million, an improvement from $74.5 million in the same period of 2024.
  • Net loss for the nine months ended September 30, 2025, was $216.2 million, an improvement from $270.3 million in the same period of 2024.
  • Revenue for the three months ended September 30, 2025, was $0.4 million, a slight decrease from $0.4 million in Q3 2024.
  • Revenue for the nine months ended September 30, 2025, was $1.2 million, a significant decrease from $6.6 million in the same period of 2024, primarily due to the absence of commercial spaceflights in 2025.
  • Total operating expenses decreased to $66.5 million in Q3 2025 (down 19% from Q3 2024) and to $225.8 million for the nine months (down 25% from 9M 2024), driven by reductions in spaceline operations, research and development, and selling, general and administrative costs.
  • Cash, cash equivalents, and restricted cash totaled $158.8 million as of September 30, 2025, with marketable securities of $264.8 million.
  • Capital expenditures significantly increased to $155.9 million for the nine months ended September 30, 2025, up from $86.1 million in the prior year, reflecting substantial investment in next-generation vehicles.
  • The company sold 30.0 million shares under the 2024 At-The-Market (ATM) Program, generating $109.2 million in gross proceeds during the nine months ended September 30, 2025.
  • There are 675 future astronaut reservations, representing approximately $189 million in expected future spaceflight revenue upon completion of the spaceflights.

Sentiment

Score: 4

Explanation: While the company reported narrower losses and demonstrated cost control, the significant drop in revenue due to the pause in commercial flights and continued high capital expenditures for development indicate a prolonged period before profitability. The ongoing reliance on ATM offerings for liquidity and the explicit mention of potential future capital raises beyond 12 months temper optimism, despite progress on next-generation vehicles.

Positives

  • Net loss significantly narrowed for both the three-month ($64.4 million vs. $74.5 million) and nine-month ($216.2 million vs. $270.3 million) periods compared to the prior year, indicating improved financial performance.
  • Operating expenses decreased across all categories (Spaceline operations, Research and Development, Selling, General and Administrative) for both the three and nine-month periods, demonstrating effective cost management.
  • Progress continues on the development of Delta Class spaceships and next-generation launch vehicles, which are critical for future growth and increased flight rates.
  • A preliminary settlement has been reached in the Lavin class action lawsuit for $8.5 million, with $6.1 million expected to be covered by insurance, reducing the company's net liability to $2.4 million.
  • Management believes current capital is adequate to sustain operations for at least the next twelve months.

Negatives

  • Revenue significantly decreased to $1.2 million for the nine months ended September 30, 2025, from $6.6 million in the prior year, primarily due to the pause in commercial spaceflights.
  • Cash, cash equivalents, and restricted cash decreased to $158.8 million as of September 30, 2025, from $210.9 million at the beginning of the period.
  • Marketable securities, short-term, decreased to $264.8 million from $384.6 million at December 31, 2024.
  • Total stockholders' equity decreased to $225.9 million from $322.3 million at December 31, 2024.
  • Customer deposits decreased to $80.2 million from $84.5 million at December 31, 2024, indicating a slight reduction in future astronaut commitments.
  • Interest income decreased significantly due to lower average balances of marketable securities and interest-bearing accounts.
  • The company continues to operate at a substantial net loss, reflecting its pre-profitability development stage.
  • Significant share dilution occurred due to the at-the-market offering programs, with weighted-average shares outstanding nearly doubling year-over-year.

Risks

  • Any delay in future commercial flights of the spaceflight fleet.
  • Ability to successfully develop and test next-generation vehicles, and the associated time and costs.
  • The safety of spaceflight systems.
  • Development of markets for commercial spaceflight and commercial research and development payloads.
  • Ability to effectively market and sell spaceflights and convert backlog or inbound inquiries into revenue.
  • Ability to achieve or maintain profitability.
  • Expected capital requirements and the availability of additional financing.
  • Ability to attract or retain highly qualified personnel.
  • The effect of terrorist activity, armed conflict (including any escalation of hostilities arising out of the ongoing conflicts between Russia and Ukraine, Israel and Hamas, Israel and Iran, or other geopolitical conflicts), natural disasters, or pandemic diseases on the economy generally, on future financial or operational results, or access to additional financing.
  • Consumer preferences and discretionary purchasing activity, which can be significantly adversely affected by unfavorable economic or market conditions.
  • Extensive and evolving government regulation that impacts operations, including potential negative effects of changes in United States tariff and import/export regulations.
  • Risks associated with international expansion.
  • Ability to maintain effective internal control over financial reporting and disclosure procedures.
  • Ability to continue to use, maintain, enforce, protect, and defend owned and licensed intellectual property, including the Virgin brand.
  • Unpredictable costs and significant risks, uncertainties, and contingencies associated with the commercial launch of the spaceflight program and the anticipated expansion of the fleet.

Future Outlook

Virgin Galactic anticipates its Delta Class spaceship flight test program to begin in the third quarter of 2026, with the first commercial spaceflight (a research flight) expected in the fourth quarter of 2026. Private astronaut spaceflights are projected to commence six to eight weeks after the initial commercial flight. The company plans to open tranches of sales reservations in the first quarter of 2026 as it approaches the start of commercial service. Management believes current capital is sufficient for the next twelve months but may require additional financing beyond that period to sustain operations and expand the fleet.

Management Comments

  • "We are continuing the development of our new Delta Class spaceships and are progressing through our build milestones."
  • "Following the completion of the non-recurring engineering work on our Delta Class spaceships, we have redeployed engineering resources to the next phase of design for our next-generation launch vehicle."
  • "We are exploring the opportunity to use a derivative model of our launch vehicle as a High-Altitude, Long-Endurance (HALE) aircraft, which we believe could be utilized for several types of government and research purposes."
  • "We believe that our current capital is adequate to sustain our operations for at least the next twelve months."
  • "Changing circumstances may cause us to consume capital significantly faster than we currently anticipate, and we may need to spend more money than currently expected because of circumstances beyond our control."
  • "We expect to generate revenue from our spaceflight program, which is expected to commence with spaceflights in the fourth quarter of 2026."
  • "To the extent this source of capital as well as sources of capital described above are insufficient to meet our needs, we may need to seek additional debt or equity financing."

Industry Context

Virgin Galactic operates in the nascent but growing commercial space travel and research industry. Its focus on developing next-generation Delta Class spaceships and launch vehicles aims to increase flight capacity and frequency, positioning it to capture a larger share of the private astronaut and scientific payload market. The exploration of a High-Altitude, Long-Endurance (HALE) aircraft derivative suggests a potential diversification into government and research applications, broadening its market reach beyond pure space tourism. The current pause in commercial flights for fleet development is a strategic move to scale operations, a common challenge for companies in this capital-intensive, high-technology sector.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Equity Incentive Plan AmendmentThird Amended and Restated Virgin Galactic Holdings, Inc. 2019 Incentive Award Plan (Third A&R Plan) adopted, increasing shares available by 5.5 million to 7,670,437 and extending award grant rights through June 5, 2035.2025-06-01Increases the pool of shares available for equity compensation, potentially impacting dilution but also aiding in talent retention and motivation.
Equity Incentive Plan AmendmentAmended and Restated Virgin Galactic Holdings, Inc. 2023 Employment Inducement Incentive Award Plan (A&R Inducement Plan) adopted, increasing shares available by 1.0 million to 1,140,000.2025-06-01Expands the ability to grant inducement awards to attract new talent.
Employee Stock Purchase Plan AdoptionVirgin Galactic Holdings, Inc. 2025 Employee Stock Purchase Plan (ESPP) adopted, authorizing 2.5 million shares for issuance, allowing eligible employees to purchase common stock at a discount.2025-06-01Enhances employee benefits and encourages employee ownership, potentially improving retention and alignment of interests.
Bylaws AmendmentAmended and Restated By-Laws of Virgin Galactic Holdings, Inc. became effective.2025-08-28Specific details of the impact are not provided in the 10-Q, but generally, bylaw amendments can affect shareholder rights, board structure, and corporate operations.

Legal Proceedings

  • Lavin v. Virgin Galactic Holdings, Inc. (Class Action): A putative class action alleging false and misleading statements regarding ship safety and commercial flight success. A Memorandum of Understanding for an $8.5 million settlement was executed on July 18, 2025, with $6.1 million expected to be covered by insurance. The net settlement expense recorded was $2.4 million. Preliminary court approval is sought, with payments expected in early 2026 and final approval in 2026.
  • Consolidated Derivative Action (Spiteri, Grenier, Laidlaw, St. Jean, Gera): Consolidated derivative complaints alleging violations of Exchange Act sections and claims of breach of fiduciary duty, abuse of control, gross mismanagement, waste of corporate assets, and unjust enrichment. Parties are exploring a potential resolution, with a status report due by January 10, 2026.
  • Abughazaleh v. Branson et al. (Derivative Action): A derivative complaint alleging violations of Section 14(a) and breach of fiduciary duty, currently stayed.
  • Espinosa v. Branson et al. (Derivative Action): A derivative complaint alleging breach of fiduciary duty and unjust enrichment. An amended complaint was filed on October 29, 2025, after another plaintiff (Molnar) intervened.

Related Party Transactions

  • The company licenses its brand name from Virgin Enterprises Limited (VEL), an affiliate. Royalties payable are a low single-digit percentage of gross sales or a fixed amount that ramps up to a low-seven figure amount annually. Royalties payable on sponsorships are a mid-double-digit percentage of related gross sales.
  • Royalty expenses incurred were $1.7 million for the nine months ended September 30, 2025, compared to $1.0 million for the same period in 2024.

Stakeholder Impact

  • Shareholders: Experience dilution from ongoing ATM programs, but also benefit from capital raised for development. Continued losses and delayed commercial flights impact shareholder value. Legal settlements and ongoing litigation create uncertainty.
  • Employees: Benefit from new equity incentive plans (Third A&R Plan, A&R Inducement Plan) and the Employee Stock Purchase Plan, which can aid in retention and motivation.
  • Customers (Future Astronauts): Face continued delays in commercial flight availability but have their deposits held. The development of Delta Class promises increased flight capacity in the future.
  • Creditors: Convertible senior notes remain a significant liability, but the company states it has adequate liquidity for the next 12 months.
  • Suppliers/Contractors: Benefit from increased capital expenditures for next-generation vehicle development, particularly sub-contractors for manufacturing and design.

Next Steps

  • Continue development of Delta Class spaceships and next-generation launch vehicles.
  • Commence Delta Class flight test program in Q3 2026.
  • Conduct first commercial spaceflight (research flight) in Q4 2026.
  • Commence private astronaut spaceflights 6-8 weeks after the first commercial flight.
  • Open tranches of sales reservations in Q1 2026.
  • Make payments for the Lavin Action settlement in early 2026.
  • Await final court approval and judgment for the Lavin Action settlement in 2026.
  • Submit a status report on potential resolution discussions for the Consolidated Derivative Action and St. Jean Action by January 10, 2026.
  • Potentially seek additional debt or equity financing beyond the next twelve months.

Key Dates

DateDescription
2022-01-01Company completed an offering of $425 million aggregate principal amount of convertible senior notes.
2022-02-21First derivative complaint (Spiteri v. Branson et al.) filed against the Company's current and former officers and directors.
2022-03-01Second derivative complaint (Grenier v. Branson et al.) filed.
2022-05-04The Spiteri and Grenier Actions were consolidated into In re Virgin Galactic Holdings, Inc. Derivative Litigation.
2022-09-21Third derivative complaint (Laidlaw v. Branson et al.) filed.
2022-11-07Court granted in part and denied in part defendants' motion to dismiss the amended complaint in the Lavin Action.
2022-12-12Plaintiffs filed a second amended complaint in the Lavin Action.
2022-12-13Fourth derivative complaint (St. Jean v. Branson et al.) filed.
2023-02-13Abughazaleh derivative complaint filed against certain current and former officers and directors.
2023-06-01Company entered into a distribution agency agreement for an at-the-market offering program (2023 ATM Program) for up to $400 million of common stock.
2023-08-08Court granted in part and denied in part defendants' motion to dismiss the second amended complaint in the Lavin Action.
2023-09-30The Laidlaw Action was consolidated into the Consolidated Derivative Action.
2023-12-19Court denied plaintiffs' motion for reconsideration of the dismissal order in the Lavin Action.
2024-03-27Defendants moved for judgment on the pleadings as to the remaining Section 10(b) insider trading claim against Branson in the Lavin Action.
2024-04-02Court stayed briefing on defendants' motion for judgment on the pleadings in the Lavin Action.
2024-04-09Molnar and Tubbs derivative complaint filed against certain current and former officers and directors.
2024-05-01Plaintiffs filed anticipated motion for leave to add a new representative plaintiff in the Lavin Action.
2024-07-02Court granted plaintiffs' motion to add a new representative plaintiff in the Lavin Action.
2024-07-08Defendants withdrew their motion for judgment on the pleadings in the Lavin Action.
2024-07-11Fifth derivative complaint (Gera v. Branson et al.) filed.
2024-07-16Plaintiffs in Molnar and Tubbs action filed a joint stipulation of voluntary dismissal without prejudice.
2024-07-17Court granted plaintiffs' stipulation and entered an order of dismissal in the Molnar and Tubbs action.
2024-08-21Plaintiffs filed a third amended complaint in the Lavin Action, designating new lead plaintiffs and adding Montgomery Brantley.
2024-09-03Espinosa derivative complaint filed against certain current and former officers and directors.
2024-09-11Defendants filed an answer to plaintiffs' third amended complaint in the Lavin Action.
2024-09-12The Gera Action was consolidated into the Consolidated Derivative Action.
2024-10-12Plaintiffs filed a motion to certify their proposed class in the Lavin Action.
2024-11-01Company terminated the 2023 ATM Program, having sold 12.8 million shares for $396.2 million gross proceeds.
2024-11-01Company entered into an open market sale agreement for a new at-the-market offering program (2024 ATM Program) for up to $300 million of common stock.
2024-11-0663,200,245 shares of the Company's common stock were outstanding.
2024-12-20Defendants filed an opposition to plaintiffs' motion to certify class in the Lavin Action.
2025-01-10Status report detailing progress of resolution discussions for the Consolidated Derivative Action and St. Jean Action is due.
2025-01-24Plaintiffs filed their reply to defendants' opposition to class certification in the Lavin Action.
2025-02-12Plaintiffs submitted a letter request to the Court seeking permission to file a motion for leave to file a Fourth Amended Complaint in the Lavin Action.
2025-03-17Court granted plaintiffs' request to file a motion for leave to amend in the Lavin Action.
2025-03-21Defendants filed a sur-reply to plaintiffs' reply on class certification in the Lavin Action.
2025-03-26Plaintiffs filed their motion for leave to file a Fourth Amended Complaint in the Lavin Action.
2025-04-01The Third Amended and Restated Virgin Galactic Holdings, Inc. 2019 Incentive Award Plan (Third A&R Plan) and the Virgin Galactic Holdings, Inc. 2025 Employee Stock Purchase Plan (ESPP) were adopted by the board of directors.
2025-04-11Defendants filed their opposition to plaintiffs' motion for leave to amend in the Lavin Action.
2025-04-23Plaintiffs filed their reply to defendants' opposition to motion for leave to amend in the Lavin Action.
2025-06-01The Third A&R Plan, the Amended and Restated Virgin Galactic Holdings, Inc. 2023 Employment Inducement Incentive Award Plan (A&R Inducement Plan), and the ESPP became effective upon stockholder approval.
2025-07-01The initial six-month offering period of the ESPP commenced.
2025-07-18Plaintiffs and defendants executed a Memorandum of Understanding outlining settlement terms for the Lavin Action.
2025-08-12Court granted plaintiff Crystal Molnar's unopposed motion to intervene in the Espinosa action.
2025-08-14Company and Individual Defendants filed a motion to dismiss the complaint in the Espinosa action.
2025-08-28Amended and Restated By-Laws of Virgin Galactic Holdings, Inc. became effective.
2025-09-30End of the quarterly reporting period.
2025-10-29Plaintiffs Espinosa and Molnar filed an amended complaint in the Espinosa action.
2025-11-04Plaintiffs asked the Court to preliminarily approve the Lavin Action settlement.
2025-11-13Date of filing of this Quarterly Report on Form 10-Q.
2026-01-01Expected opening of tranches of sales reservations for spaceflights.
2026-01-01Expected payments in connection with the Lavin Action settlement.
2026-03-31Expected final approval of the Lavin Action settlement and judgment.
2026-07-01Expected commencement of flight test program for Delta Class spaceships.
2026-10-01Expected first commercial spaceflight (research flight) for Delta Class spaceships.
2026-11-15Expected commencement of private astronaut spaceflights (6-8 weeks after first commercial flight).
2027-02-01Maturity date for the 2027 Convertible Senior Notes.

Recommendation

hold

Virgin Galactic is in a critical transition phase, investing heavily in its next-generation Delta Class spaceships to scale operations. While the narrowing of net losses and reduction in operating expenses are positive signs of cost management, the significant drop in revenue due to the pause in commercial flights and ongoing reliance on equity financing (ATM program) highlight the long path to profitability. The projected commercial flight timeline in late 2026 means a prolonged period without substantial revenue from its core business. The stock is highly speculative, driven by future potential rather than current financials. A 'hold' recommendation is appropriate for investors already in the stock, acknowledging the high risk/reward profile. New investors should exercise extreme caution due to the significant execution risks and capital requirements before sustained commercial operations begin.

Keywords

Virgin Galactic, SPCE, Space Travel, Commercial Spaceflight, Delta Class, Space Tourism, Aerospace, SEC Filing, 10-Q, Financial Results, Net Loss, Capital Expenditures, ATM Program, Legal Settlement, Future Astronauts, Research and Development

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.